These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Rifampicin in the treatment of patients with chronic destructive tuberculosis complicated by drug intolerance and Mycobacterium drug resistance]. Adamovich VN, Kolomytseva OS, Gur'ian IE. Vrach Delo; 1975 Jan; (1):95-9. PubMed ID: 806177 [No Abstract] [Full Text] [Related]
5. Studies for the determination of clinically available criteria of resistance of tubercle bacilli to rifampicin. Gomi J, Yanagisawa K, Murohashi T. Kekkaku; 1970 Oct; 45(10):317-22. PubMed ID: 4991063 [No Abstract] [Full Text] [Related]
7. [Bacteriologic negation and anatomic development in pulmonary specimens after rifampicin treatment of less than 10 months (10 cases)]. Constans P, Parrot R, Coury C. Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):511-8. PubMed ID: 4994883 [No Abstract] [Full Text] [Related]
15. [Rifampicin and positive microscopic findings in a negative Mycobacterium tuberculosis culture]. Begović N, Drinković I, Popović I. Plucne Bolesti Tuberk; 1972 Jun; 24(3):157-62. PubMed ID: 4632836 [No Abstract] [Full Text] [Related]
16. The pattern of resistance development to rifampicin in Mycobacterium tuberculosis. Tsukamura M. Tubercle; 1972 Jun; 53(2):111-7. PubMed ID: 4625182 [No Abstract] [Full Text] [Related]
17. [The critical concentration of clinical rifampicin resistance for tubercle bacilli and the acquirement pattern of rifampicin resistance of tubercle bacilli on Kirchner's semi-liquid agar media]. Tamura M, Yamazaki A, Tamura T, Takano S, Yamazaki M. Kekkaku; 1973 Jun; 48(6):247-53. PubMed ID: 4200023 [No Abstract] [Full Text] [Related]